DK0615446T3 - Retard drug containing a nanosol dihydropyridine derivative and its preparation - Google Patents
Retard drug containing a nanosol dihydropyridine derivative and its preparationInfo
- Publication number
- DK0615446T3 DK0615446T3 DK92924551.2T DK92924551T DK0615446T3 DK 0615446 T3 DK0615446 T3 DK 0615446T3 DK 92924551 T DK92924551 T DK 92924551T DK 0615446 T3 DK0615446 T3 DK 0615446T3
- Authority
- DK
- Denmark
- Prior art keywords
- nanosol
- preparation
- drug containing
- dihydropyridine derivative
- retard drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5169—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2063—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C1/00—Photosensitive materials
- G03C1/005—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein
- G03C1/04—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein with macromolecular additives; with layer-forming substances
- G03C1/047—Proteins, e.g. gelatine derivatives; Hydrolysis or extraction products of proteins
- G03C2001/0471—Isoelectric point of gelatine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Slow-release medicaments containing a pharmacologically active dihydropyridine derivate as a pharmaceutically applicable nanosol have considerably improved bioavailabilities and resorption rates, with an increased tolerability of the active substances.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4140194A DE4140194C2 (en) | 1991-12-05 | 1991-12-05 | Medicament containing a dihydropyridine derivative in nanosol form and its preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0615446T3 true DK0615446T3 (en) | 1996-02-26 |
Family
ID=6446394
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92924551.2T DK0615446T3 (en) | 1991-12-05 | 1992-12-04 | Retard drug containing a nanosol dihydropyridine derivative and its preparation |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0615446B1 (en) |
AT (1) | ATE130190T1 (en) |
AU (1) | AU3080692A (en) |
DE (2) | DE4140194C2 (en) |
DK (1) | DK0615446T3 (en) |
ES (1) | ES2082524T3 (en) |
GR (1) | GR3018930T3 (en) |
WO (1) | WO1993010770A1 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3421468A1 (en) * | 1984-06-08 | 1985-12-19 | Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim | LIPID NANOPELLETS AS A CARRIER SYSTEM FOR MEDICINAL PRODUCTS FOR PERORAL USE |
DE3515335C2 (en) * | 1985-04-27 | 1995-01-26 | Bayer Ag | Pharmaceutical preparation containing dihydropyridines and process for their preparation |
NL194638C (en) * | 1986-12-19 | 2002-10-04 | Novartis Ag | Hydrosol containing solid particles of a pharmaceutically active substance and pharmaceutical preparation containing this hydrosol. |
CA1324083C (en) * | 1987-03-09 | 1993-11-09 | Tetsu Miyoshi | Pharmaceutical preparations containing non-steroidal anti-inflammatory agents |
EP0349428B1 (en) * | 1988-06-30 | 1993-01-20 | Centre National De La Recherche Scientifique (Cnrs) | Process for preparing colloidal dispersive protein systems in the shape of nanoparticles |
US5007790A (en) * | 1989-04-11 | 1991-04-16 | Depomed Systems, Inc. | Sustained-release oral drug dosage form |
-
1991
- 1991-12-05 DE DE4140194A patent/DE4140194C2/en not_active Expired - Fee Related
-
1992
- 1992-12-04 AU AU30806/92A patent/AU3080692A/en not_active Abandoned
- 1992-12-04 AT AT92924551T patent/ATE130190T1/en not_active IP Right Cessation
- 1992-12-04 DK DK92924551.2T patent/DK0615446T3/en active
- 1992-12-04 WO PCT/DE1992/001014 patent/WO1993010770A1/en active IP Right Grant
- 1992-12-04 DE DE59204376T patent/DE59204376D1/en not_active Expired - Fee Related
- 1992-12-04 ES ES92924551T patent/ES2082524T3/en not_active Expired - Lifetime
- 1992-12-04 EP EP92924551A patent/EP0615446B1/en not_active Expired - Lifetime
-
1996
- 1996-02-07 GR GR960400336T patent/GR3018930T3/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE59204376D1 (en) | 1995-12-21 |
ATE130190T1 (en) | 1995-12-15 |
DE4140194A1 (en) | 1993-06-09 |
WO1993010770A1 (en) | 1993-06-10 |
EP0615446B1 (en) | 1995-11-15 |
EP0615446A1 (en) | 1994-09-21 |
ES2082524T3 (en) | 1996-03-16 |
AU3080692A (en) | 1993-06-28 |
GR3018930T3 (en) | 1996-05-31 |
DE4140194C2 (en) | 1998-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA03011538A (en) | Medicinal compositions. | |
DE1001772T1 (en) | IMPROVED ADMINISTRATION TECHNOLOGY FOR MULTIPLE ADMINISTRATION | |
CY1117470T1 (en) | SOLID DOSAGE PREPARATIONS WITH IMPROVED ANIMAL ADJUSTMENT | |
NO971206D0 (en) | Prolonged-frigjöringsformulering | |
SE9301171D0 (en) | PHARMACEUTICAL COMPOSITION CONTAINING LIPOPHILIC DRUGS | |
NO20053106L (en) | Oral, extended-release analgesic dosage form. | |
HUP9802221A2 (en) | Antiparasitic marcfortines and paraherquamides | |
ATE424810T1 (en) | A DELAYED-RELEASE TABLET CONTAINING A HYDROCOLLOID AND A CELLULOSE ETHER | |
ATE292453T1 (en) | ANTIVIRAL DRUG | |
HU229443B1 (en) | Betha-carboline particulate form, pharmaceutical compositions containing it, their preparations and their use | |
ATE173627T1 (en) | MEDICAL COMPOSITION | |
TW221441B (en) | ||
NO995127D0 (en) | Stabilized tibolone mixtures | |
EP0341209A3 (en) | Physiologically active substances, a process for preparation and pharmaceutical compositions thereof | |
NO20031410L (en) | Use of distamycin derivatives for the manufacture of drugs | |
TW366284B (en) | Pharmaceutical antitussive composition of delta-receptor antagonist | |
DK0615446T3 (en) | Retard drug containing a nanosol dihydropyridine derivative and its preparation | |
ATE296115T1 (en) | SITE-SPECIFIC DRUG ADMINISTRATION | |
DE69635775D1 (en) | MEDICAMENT AGAINST PULMONARY HEART PROBLEMS | |
DK0615439T3 (en) | Iburprofen-containing retard drug and its use | |
GB9420748D0 (en) | 1,5 benzodiazepine derivatives | |
AP9200405A0 (en) | Pharmaceutical formulations comprised of micronised halofantrine. | |
HUP0104941A2 (en) | Blister containing more dose form of medicament | |
ATE326974T1 (en) | BLOCKING THE DEPOSIT OF GERMS IN BIRDS |